Forbes September 11, 2024
Robert Hart

Topline

Ozempic maker Novo Nordisk on Wednesday said data showed its hotly anticipated weight loss pill prompts greater and more rapid weight loss than its blockbuster treatment Wegovy, amid competition from Mounjaro maker Eli Lilly, pharma titans like Pfizer and biotech upstarts.

Key Facts

When Will Weight Loss Pills Be Available?

The best weight loss drugs on the market at the moment, Lilly’s tirzepatide and Novo’s semaglutide, are only available as injections, which many people find off putting and can be challenging and expensive to produce. Pharma titans like Pfizer, Roche and Novo, are all racing to crack into this lucrative sector with alternatives like weight loss pills and early data suggests they could be as, or even more, effective...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Clinical Trials, Pharma / Biotech, Trends
How Life Sciences Can Drive Innovation And Sustainability In Returns Management
How Americans feel about weight-loss drugs, in 3 charts
Tariffs on China threaten could drive up drug costs, exacerbate shortages: 5 notes
Drugmakers prep for bird flu outbreak, despite continued low risk
Heart health differences in men and women: Tiny RNA molecules play key role, study finds

Share This Article